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Abstract 
Background: This study assessed novel approach of using highly lytic phages against methicillin-susceptible Staphy-
lococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA) biofilms with and without biofilm 
extracellular matrix- disrupting chemical.
Method: The resultant phage-based control was assessed in relation to the type of biofilm extracellular matrix 
namely, polysaccharide intercellular adhesion (PIA) or proteinacious fibronectin-binding protein A (FnBPA). The 
biofilms were formed in vitro by 24 h incubation of bacteria in 96 wells microtiter plates at room temperature. The 
formed biofilms were assessed by tissue culture plate (TCP). Moreover, the nature of the biofilm was assessed by scan-
ning electron microscopy (SEM) and PCR assay for detecting PIA genes, ciaA-D and FnBPA genes.
Results: this study showed that applied phages with 0.08 % benezenthonium chloride, for PIA biofilms, and 0.06 % 
ethanol, for proteinacious FnBPA biofilms, exerted 100 % eradication for MSSA biofilms and about 78 % of MRSA 
biofilms. The phage-based control of biofilms with chemical adjuvant showed significantly higher efficiency than that 
without adjuvant (P < 0.05). Moreover, FnBPA biofilms were more common in MRSA than in MSSA while PIA biofilms 
were more common in MSSA than in MRSA. And the most resistant type of biofilms to phage-based control was 
FnBPA in MRSA where 50 % of biofilms were reduced but not eradicated completely.
Conclusions: It is concluded that PIA-disturbing agent and protein denaturing alcohol can increase the efficiency 
of attacking phages in accessing host cell walls and lysing them which in turn lead to much more efficient MRSA and 
MSSA biofilm treatment and prevention.
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Background
Staphylococcus aureus (S. aureus) is the prime cause of 
hospital-associated infections. According to antibiotic 
resistance profiling, Staphylococcus aureus is divided into 
Methicillin-susceptible S. aureus (MSSA) and Methicillin-
resistant S. aureus (MRSA) which represents an especially 
big threat to the public-health system [1]. Traditionally, 
MRSA infections have been limited to hospitals and pre-
disposed individuals, such as the elderly, immunocom-
promised and patients undergoing surgery [2, 3]. More 
recently, however, MRSA infections have occurred out-
side of the hospital setting [4]. Community-associated 
(CA)-MRSA were first reported in the Northern USA, 
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where they caused fatal infections in otherwise healthy 
children [5]. Later, CA-MRSA has become a global prob-
lem, with the most serious epidemic seen in the USA [6]. 
According to recent estimates, MRSA infections cause 
more deaths annually in the USA than HIV/AIDS [7].
Staphylococci are usually related to infections of 
implanted medical devices. The predominant species 
isolated in these infections are Staphylococcus epider-
midis and Staphylococcus aureus. Moreover, most of the 
attached S. aureus are in fact MRSA. The main virulent 
factor of these bacteria is the ability to form biofilm on pol-
ymeric surfaces to which it adheres and colonizes artificial 
materials [4, 8]. Biofilms are a population of multilayered 
cells growing on a surface and enclosed in exopolysaccha-
ride matrix. Biofilm formations are considered to be a four 
step process: (a) attachment, (b) colonization and multipli-
cation, (c) maturation and (d) dispersion.
Antibiotic resistance and biofilm-forming capacity 
contribute to the success of Staphylococcus aureus as a 
human pathogen in both healthcare and community set-
tings [9]. The biofilm matrix is a complex mixture of mac-
romolecules, including exopolysaccharides, proteins, and 
DNA. These virulence factors do not function indepen-
dently of each other and the biofilm phenotype expressed 
by clinical isolates of S. aureus is influenced by acquisi-
tion of the methicillin resistance gene mecA. Methi-
cillin-sensitive S. aureus strains commonly produce an 
icaADBC operon-encoded polysaccharide intercellular 
adhesin (PIA)-dependent biofilm. In contrast, the release 
of extracellular DNA (eDNA) and cell surface expression 
of a number of sortase-anchored proteins, and the major 
autolysin have been implicated in the biofilm phenotype 
of MRSA isolates [9]. The main exopolysaccharide of the 
SA biofilm matrix is a polymer of poly-N-acetylglucosa-
mine, termed polysaccharide intercellular adhesin (PIA) 
or poly-N-acetylglucosamine (PNAG), whose synthe-
sis depends on the enzymes encoded by the icaADBC 
operon in ica locus [10, 11]. Among ica genes, icaA and 
icaD have been reported to play a significant role in bio-
film formation in MSSA and MRSA [12, 13].
However, the presence of PIA/PNAG exopolysaccha-
ride is not found in all biofilms of MSSA or MRSA strains. 
Several studies have uncovered the existence of S. aureus 
isolates able to produce alternative biofilm matrixes [14–
16]. When this occurs, it appears that proteins usually 
take the responsibility for mediating cell-to-cell interac-
tions and multicellular behavior. More recently, two inde-
pendent research groups have described a novel S. aureus 
biofilm phenotype mediated by the fibronectin-bind-
ing proteins, FnBPA and FnBPB, being FnBPA is more 
important and more constantly associated with proteina-
cious biofilm of MSSA or MRSA [17, 18]. Therefore, there 
are two types of biofilms for MSSA and MRSA bacteria, 
polysaccharide- or PIA- based biofilm and proteinacious, 
or FnBPA-based, biofilms. Nevertheless, the behaviour of 
these two types of biofilms was not studied well.
The rate at which S. aureus can develop or acquire 
resistance to new antibiotics seems to be higher than the 
rate at which new antibiotics are discovered and devel-
oped. Accordingly, new control measures, rather than 
antibiotics, are needed in action to contain the increasing 
hazard of MRSA [19]. Moreover, there is a need to a safe, 
widely accepted, and revolutionary measures for the con-
trol and therapy of MRSA. Worldwide, an estimated 2 bil-
lion people carry some form of S. aureus; of these, up to 
53 million (2.7 % of carriers) are thought to carry MRSA 
[20]. One of the promising new measures of MRSA con-
trol is bacteriophages (phages). Phages are present abun-
dantly in the environment and humans ingest billions of 
phages daily without harm; therefore, they are considered 
safe for humans and animals [21].
However, the most challenging problem for MRSA con-
trol, either using phages or other agents, is their ability to 
produce highly protective biofilms. Biofilms of MRSA are 
considered the main source for providing virulent bac-
terial cells ready to spread infection in hospitals and in 
community. Therefore, in our opinion, there is a need to 
formulate an effective non-antibiotic phage-based con-
trol for MRSA and MSSA biofilms. In the current study, 
anti-MSSA and anti-MRSA phages were optimized and 
designed and were used to assess phage control to MSSA 
and MRSA biofilms. Moreover, the nature of intercellular 
adhesion of MSSA and MRSA biofilms, PIA or FnBPA-
based biofilms, were studied and their response to phage-
based control was accordingly evaluated.
Methods
Sampling of bacteria
Seven isolates of MRSA and 10 isolates of MSSA were 
chosen to be used in the current study. These isolates 
were collected, as part of the routine hospital work, 
from clinical wound samples in three hospitals in Slena-
gor state in Malaysia, Hospital Serdang, Hospital Kajang 
and Hospital HUKL using Microbact GNB 12A system 
(Oxoid, UK) with 99 % confirmatory rate. The diagnosed 
S. aureus bacteria were then subjected to a series of selec-
tive and differential media to identify MRSA bacteria 
which are the most important target of this study. The 
current study has been approved by the ethical commit-
tee of University Putra Malaysia.
Isolation, identification, and propagation of MSSA 
and MRSA
Bacteria were swabbed from infected regions and were 
inoculated into nutrient broth (NB) (Merck, Germany) 
for 18  h at 37  °C. Next day, grown bacteria in NB were 
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ABC streaked onto nutrient agar (NA) (Merck, Ger-
many) and incubated for 18 h at 37 °C. Next day, different 
colonies were grown, the suspected colonies of S. aureus 
were streaked onto a selective and differential medium 
namely, Mannitol salt agar (MSA) (Merck, Germany) 
for 18 h at 35 °C. Next day, the grown bacteria in yellow 
colonies were confirmed as S. aureus. In addition, light 
microscopy was used as a supportive tool for S. aureus 
diagnosis. In order to identify MRSA strains, MRSA 
chromogenic agar or MRSA agar (Merck, Germany) was 
used. MRSA agar is composed of 11 g peptone mixture, 
1.9 g chromogenic substrate, 78 g growth factors and 12.5 
biological agar. In addition, MRSA agar was used with 
added oxacillin (6  mg/L) (Sigma, USA) in the prepara-
tion of MRSA agar. MRSA agar was used as a screening 
medium for the determination of methicillin resistance 
and oxacillin resistance in Staphylococcus aureus. The 
presence of growth indicated oxacillin and methicillin 
resistance. Lack of growth indicated that the strain lacks 
the mecA resistance gene. Only the non-inhibited colo-
nies in MRSA selective agar were considered MRSA.
Reference strains of MRSA and MSSA
Reference strains of MRSA and MSSA were involved in 
the current study along with the isolated and identified 
clinical samples. Two reference strains of MRSA were 
used namely, ATCC 700699 and ATCC 43300 and two 
MSSA reference strains were used, namely, ATCC 11987 
and ATCC 27691.
The strategy of the current study
First, the biofilm formation is compared between MSSA 
and MRSA bacteria. Second, the type of biofilms pro-
duced are assessed and categorized into PIA-based bio-
films or proteinacious FnBPA-based biofilms in both 
MSSA and MRSA using SEM and PCR detection for 
icaA-D genes, which are responsible for PIA synthesis, 
and FnBPA gene, which is responsible for fibronectin-
binding protein synthesis. Third, the MSSA and MRSA 
biofilms are challenged with high titre of specific lytic 
phages for disintegrating the biofilm matrix and lysing 
the integrated bacteria. Fourth, the effectiveness of the 
phage-based control for MRSA and MSSA biofilms is 
assessed in comparison with MSSA versus MRSA and 
PIA-based versus FnBPA-based biofilms. In addition, the 
augmentation of the efficiency of phage-based control 
was assessed by coupling attacking phages with PIA-dis-
turbing or protein-denaturing chemical adjuvants.
Isolation of wild phages to MSSA and MRSA
Phages to MSSA and MRSA were isolated from 3 dif-
ferent sources; Hospital environmental dirt, sew-
age disposal, and cattle waste. Crude specimens of 
approximately 50  g of environmental dirt, sewage dis-
posal, or cattle waste were each collected in a sterile sam-
ple collection tube (100 ml). The procedure pursued was 
done according to [22] with some modification. One to 
three grams of each specimen were transferred into 90 ml 
of nutrient broth (NB) and vortexed for 30 s. Then 1 ml 
of 8 h NB cultures of the target MRSA clinical isolate or 
reference strains was added and incubated at 37 °C. After 
18 h, 10 ml of the mixture were withdrawn into a sterile 
15  ml test tube and centrifuged for 5  min at 5000×g at 
room temperature. Supernatant was aspirated into new 
sterile 15 ml test tubes. To the supernatant, 1 ml of chlo-
roform (Sigma, USA) was added with gentle shaking of 
tubes for 5 min then all tubes were incubated on crushed 
ice for 5  min. A milky solution appears due to bacte-
rial proteins digestion by chloroform. Centrifugation at 
5000×g for 5 min at room temperature was carried-out. 
Top aqueous supernatant was collected into 15 ml sterile 
tube and stored at 4 °C as a possible phage solution.
Testing for the presence of wild phages (phage spot lysis 
assay)
Thin bacterial lawns of clinical isolates or reference 
strains were prepared by adding 500 µl of NB 18 h cul-
tures on NA plates, allowing the liquid to soak into the 
plate. The plates were kept for 1 h at room temperature. 
Ten µl of the prepared phage suspension were spotted on 
bacterial lawns and incubated at 37 C. Plaques or lysis 
spot were observed after 6 h and 18 h. The detection of 
phage presence was based on visual appearance of lysis 
zone. Positive results were expressed by either clear or 
semi-clear (turbid) lysis zone while negative results were 
expressed by the absence of such lysis zones [23].
The approach of phage isolation and propagation
A series of optimization steps were used in order to aug-
ment the efficacy of phage hunting/isolation techniques. 
The optimization manoeuvres that were taken into 
account are:
The collection of crude phage samples was diversified 
in a way that 1  g of as minimal as 10 different samples 
from hospital dirt, sewage, and cattle waste was used to 
form the crude mixture. Samples of crude mixture (10 g) 
were placed in 100  ml Erlenmeyer flask with cotton-
plugged filled with 80 ml of NB. Then, 10 MRSA isolates 
were used together to inoculate the phage mixture with 
1 ml from each 18 h MRSA culture. After 18 h of incuba-
tion at 37 °C, 10 ml were dispensed into a sterile 15-mL 
plastic culture tubes. After centrifugation at 5000×g for 
5  min at room temperature, the supernatant was trans-
ferred into 1.5 ml sterile microcentrifuge. Then 1:10 chlo-
roform to lysate ratio was added with gentle shaking for 
5 min at room temperature in order to lyse the bacterial 
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cells followed by further 3 min incubation in crushed ice. 
The mixture was then centrifuged 5000×g for 15 min at 
room temperature and the supernatant was transferred 
into a 1.5 ml sterile microcentrifuge tubes. To this step, 
the isolated phages mixture was produced. The produced 
mixture of the isolated phages was propagated on the 
desired target bacteria lawn as it is earlier mentioned in 
the procedure of the phage spot lysis test [23].
Production of the transient phage stock
The produced mixture of the isolated phages was propa-
gated on each target bacterial lawn as it is earlier men-
tioned in the procedure of the phage spot lysis assay. Lysis 
zones, if any, were cut by a sterile scalpel and plunged 
into 300 µl of Lambda buffer in 1.5 ml sterile microcen-
trifuge tubes for 20  min with intermittent gentle shak-
ing. 1:10 chloroform to lysate ratio was added with gentle 
shaking for 5 min at room temperature in order to elute 
the phages from the agar and to lyse the bacterial cells. 
After further 3 min incubation in crushed ice the mixture 
centrifuged at 5000×g for 15  min at room temperature 
and the supernatant transferred in a 1.5 ml sterile micro-
centrifuge tubes [22].
Biofilm formation
The MRSA and MSSA biofilm formation assays were 
performed as described [24]. Sterile 96-well polystyrene 
microtiter plates were used throughout the study. Each 
assay was performed in triplicate and repeated at least 
three times. Briefly, bacterial isolates from fresh agar 
plates were inoculated in nutrient broth and incubated 
for 24 h at 37 °C in stationary condition and diluted (1 in 
50) with fresh medium. Individual wells of sterile, poly-
styrene, flat-bottom tissue culture plates were filled with 
200  μl aliquots of the diluted cultures (108 cfu/ml). The 
negative control was composed of broth only to check 
sterility and non-specific binding of media. The tissue 
culture plates were incubated for 24  h at 37  °C. After 
incubation, the content of each well was gently removed 
by tapping the plates. The wells were washed three times 
with 200  μl of phosphate buffer saline (PBS pH 7.2) to 
remove non-attached floating bacteria.
Detection of biofilm formation by tissue culture plate 
method (TCP)
The TCP assay is most widely used and was considered 
as standard test for the detection of biofilm formation. 
All isolates were screened for their ability to form biofilm 
by the TCP method as described by Christensen et  al. 
[25] with a modification in duration of incubation which 
was extended to 24  h, according to O’Toole and Kolter 
[26]. After the formation of the biofilm in tissue culture 
wells, 25 μl of 1 % solution of crystal violet were added 
to each well (this dye stains the cells but not the polysty-
rene) plates. The plates were incubated at room tempera-
ture for 15  min, rinsed thoroughly and repeatedly with 
water. Adherent cells, which usually formed biofilm on 
all side wells, were uniformly stained with crystal violet. 
Crystal violet-stained biofilm was solubilized in 200  μl 
of ethanol-acetone (80:20, vol/vol) (Merck, Germany). 
Afterwards, 100  μl were transferred to a new polysty-
rene microtiter dish which was subjected to micro ELISA 
auto reader at 570 nm wavelength. Optical densities (OD) 
of stained adherent bacteria were determined and were 
considered as indices for bacterial potential to adhere to 
surfaces and form biofilms. Experiments for each strain 
were performed in triplicate and repeated three times. 
To compensate for background absorbance, OD readings 
of wells with ethanol were used as blank and subtracted 
from all tests’ values. Biofilm production is considered 
high, moderate, weak, or zero according to the measure-
ments of OD570 nm as shown in Table 1.
Phage application on MSSA and MRSA biofilms
Optimized and isolated phages to MSSA, 12 phages, and 
MRSA, 9 phages, in lambda buffer were applied on the 
formed biofilms of 10 clinical isolates and two reference 
strains of MSSA and 7 clinical isolates and 2 reference 
strains of MRSA. Ten (10) μl of anti-SA or anti-MRSA 
1012 PFU/ml phages were applied on the formed bio-
films in the tissue culture plates with and without adju-
vant substances. Sublethal concentrations of chemical 
adjuvants together with applied phages were used in 
order to increase the permeability of the matrix of the 
biofilm as well as to increase the exposure of phage-
binding receptors on the cell walls of MSSA and MRSA 
bacteria. For PIA type biofilms, after numerous trials and 
errors using a panel of PIA/PNAG-disturbing chemicals 
[data not shown], a sublethal dose, 0.08 %, of Benzetho-
nium chloride was found to be the best in disintegrating 
PIA type biofilms when is mixed with applied phages; 
however, this dose was of no effect on either biofilms or 
phages when Benzethonium chloride was used alone. 
For FnBPA type biofilms, after numerous trial and error 
steps using a panel of protein-denaturing chemicals, sub-
lethal dose, 0.06 %, of ethanol was found to be the best 
Table 1 Classification of  biofilms formation according 
to TCP method [8]
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in disintegrating the proteinacious matrix of FnBPA type 
biofilms when is mixed with applied phages [data not 
shown]; however, this dose was of no effect on biofilms or 
phages when ethanol was used alone. Assessment of bio-
film formation was conducted by using TCP method. The 
phage-based reduction of biofilm formation was scored 
from 0 to 3.
It is noteworthy to mention that plates were kept, with-
out cover, stationary up to 24  h at room temperature. 
Microtiter plates were kept at room temperature without 
lid cover in order to mimic the sterilization conditions in 
hospitals where the sterilizing agents dry up after 30 min.
Scanning Electron Microscopy (SEM)
Formed biofilms of MSSA and MRSA were fixed in 2.5 % 
(vol/vol) glutaraldehyde (Sigma, USA) in Dulbecco PBS 
(PH 7.2) for 1.5 h, rinsed with PBS, and then dehydrated 
through an ethanol series. Samples were dried and gold–
palladium coated. SEM examinations were made on a 
JSM-840 SEM (JEOL Ltd., Tokyo, Japan) [27]. SEM was 
used in the current study for visualizing the formed bio-
films and most importantly for assessing visually the type 
of the formed biofilms whether polysaccharide- or pro-
tein- based biofilm. The IPA-based biofilm appears usu-
ally with rough crystallized surface while FnBPA-based 
biofilm appears as smooth non-crystallized surface.
PCR for the detection of icaA, icaD, and FnBPA genes
Bacterial DNA extraction
Chromosomal and plasmid DNA of the MSSA and 
MRSA bacteria were extracted using Wizard® Genomic 
DNA Purification Kit with accessory reagents (Promega, 
USA); the method of extraction was done according to 
the manufacturer’s instructions. The obtained genomic 
DNA was rehydrated by adding 100 µl DNA Rehydration 
solution. Extracted DNA 260/280 nm ratio was >1.8 and 
quality was assessed by gel electrophoresis. Then, a 5 μl 
aliquot was used as a template for PCR amplification.
PCR protocols
The primers used were synthesized by the laboratories 
of Biotechnology institute of Malaysia. For icaA-D and 
FnBPA, PCR master mixture consisted of 2  µl of 10× 
PCR buffer, 0.8 µl of a 10 mM deoxynucleoside triphos-
phate mixture, 0.7  µl of forward and reverse primers at 
concentration of 10 pmol/µl, 1.5 µl of 25 mM MgCl2, and 
0.2 µl of 0.5 U Taq DNA polymerase, and 50 ng of tem-
plate DNA; the remaining volume consisted of distilled 
water. The PCR reaction was conducted in a thermocy-
cler PCR system (PTC-110TM Model, MJ Research, Inc., 
USA). The PCR conditions, primres sequences are shown 
in Table 2.
Afterwards, 5  μl of PCR products, icaA, icaD and 
FnBPA, were electrophoresed on 2  % agarose gel using 
QIAGEN GelPilot DNA Molecular Weight Marker as a 
ladder. PCR products were separated by an electropho-
resis system at a constant voltage of 80 V for 50 min and 
were stained with 0.25 µg/ml ethidium bromide (Sigma, 
USA). PCR products were photographed under UV 
transilluminator (Vilber Lourmat, Cedex, France) and 
the photos were taken using gel documentation system, 
Bio Rad Gel Doc 2000 Model Imaging System (Bio-Rad, 
USA). The resulted bands of the PCR product for FnBPA, 
icaA, and icaD were expressed as positive and negative 
expression.
Statistical analysis
Data of the current study was analyzed by SPSS version 
12.0.1. For qualitative nominal data, Fisher exacts test 
was used. For quantitative nonparametric data, Mann–




All tested MRSA and MSSA isolates and reference strains 
developed various levels of biofilm expressed as weak, 
moderate, and high. The tested MSSA and MRSA iso-
lates and reference strains showed variable tendencies 
for biofilm formation using TCP method (Table  3). In 
order to compare the level of biofilm formation between 
MSSA and MRSA, high/moderate versus weak groups of 
biofilm production was assessed in MSSA versus MRSA. 
Although tested MRSA showed higher tendency for 
Table 2 PCR conditions, primer sequences, and PCR products of icaA, icaD, and FnBPA genes
The gene Primers sequences PCR product  
(bp)
Reference Thermal cycles
icaA F-5′-GAC CTC GAA GTC AAT AGA GGT A R-5′-CCC  
AGT ATA ACG TTG GAT ACC
814 [28] 95 °C for 5 min, 35 cycles 94 °C 30 s, 59.5 °C 
30 s, 72 °C 50 s, and 72 °C 5 min after 
conclusion of the 35 cycles [29]icaD F-5′-AGG CAA TAT CCA ACG GTA A R-5′-GTC ACG  
ACC TTT CTT ATA TT
371
FnBPA F-5′-AGGGATCCGATGGTGGAGGTGGATA-3′ R-5′- 
AGCCCGGGTGGCGTTGGTGGCACGATTGGAG
1274 [30] 95 °C 5 min, 35 cycles 94 °C 30 s, 65.5 °C 30 s, 
72 °C 1 min and 72 °C 5 min after conclu-
sion of the 35 cycles [30]
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biofilm production, no significant difference was found 
in biofilm production level between SA and MRSA 
(P = 0.36).
Types of biofilms produced
The type of biofilms produced was assessed according 
to the PCR-based detection of PIA genes, ica A and D, 
or FnBPA gene (Fig. 1). In addition, SEM screening was 
used to visualize the morphology of the produced bio-
film and to help assess the type whether PIA- or FnBPA- 
based biofilm (Fig. 2). The results of both SEM and PCR 
were in harmony. The PIA, rough crystalline morphol-
ogy as shown in SEM, was congruous with the positive 
detection of both genes, icaA and icaD while the smooth 
proteinacious morphology of the produced biofilms was 
congruous with the positive detection of FnBPA gene. 
However, only one MRSA isolate showed simultaneous 
positivity for both icaA-D and FnBPA genes but it was 
seen in SEM as smooth-surfaced proteinacious biofilm; 
therefore, it was categorized as FnBPA-based biofilm 
producing bacteria (Table 4).
According to Table 3, MRSA showed higher tendency 
to produce FnBPA type biofilms; 6 isolates with FnBPA 
type biofilms and 3 isolates with PIA type biofilms at 
ratio 2: 1. On the contrary, SA showed higher tendency 
to produce PIA type biofilms, 8 isolates, FnBPA type bio-
film, 4 isolates at ratio 2: 1. This important finding might 
provide evidence for the different responses of MRSA 
and MSSA biofilms to antibiotics, antiseptics, or bio-
logical antibacterial agents such as bacteriophages which 
were used in the current study. In addition, in MRSA, 
FnBPA biofilm type was found to be mainly of high/mod-
erate score while PIA- biofilm type was mainly of weak 
score of biofilm formation; however, these differences did 
not reach statistical significance in the level of biofilm 
production (high/moderate versus weak) between PIA 
and FnBPA types of biofilms in both MSSA and MRSA 
bacteria (P = 0.65).
Phage‑based biocontrol for MRSA and SA biofilms
Two sets of phage application experiments were assessed, 
phage application with and without chemical adjuvant 
on both types of biofilms, namely PIA and FnBPA in 
MRSA and MSSA bacteria. The magnitude of phage-
based reduction of biofilm was measured as reduction 
score which was from 0 to 3. For both types of biofilms 
in both MSSA and MRSA bacteria, it was found that 
phage application reduced effectively the formed biofilms 
(Table 5). By using phages alone without adjuvant chemi-
cal, 6/8 (75 %), 1/4 (25 %), 1/3 (33.3 %), and 1/6 (16.6 %) 
of biofilms were reduced one score in MSSA PIA, MSSA 
FnBPA, MRSA PIA, and MRSA FnBPA, respectively 
(Table 5). The current findings revealed that phage-based 
reduction is more remarkable in MSSA than in MRSA 
and in PIA than in FnBPA. Accordingly, MRSA FnBPA 
group was the least responsive to phage-based reduction 
of biofilms when phages without chemical adjuvant were 
used. On the other hand, by using phages with chemical 
adjuvant, 100  % of biofilms, whether MSSA or MRSA, 
were reduced at least one score. Moreover, 3/8 (37.5 %), 
2/4 (50 %), 2/3 (66.6 %), and 3/6 (50 %) of biofilms were 
reduced two score and more in MSSA PIA, MSSA 
FnBPA, MRSA PIA, and MRSA FnBPA, respectively 
(Table  5). Hence, it appears clearly that MRSA biofilms 
responded to the addition of the chemical adjuvant to the 
applied phages more obviously than MSSA biofilms.
By using Mann–Whitney test for comparing the 
median scores of phage reduction of biofilms among dif-
ferent groups of the study, it was found that the median 
reduction score by phages with chemical adjuvant was 
higher than by counterpart phages without chemical 
adjuvant in biofilms of MSSA PIA (P  =  0.034), MSSA 
FnBPA (P =  0.047), MRSA PIA (P =  0.11), and MRSA 
FnBPA (P = 0.0067). The current statistical design speci-
fied precisely the most responsive group to phages with 
chemical adjuvant, namely MRSA FnBPA. Since 6/9 
(66.6  %) of MRSA samples studied in the current study 
Table 3 The frequency of  MRSA and  MSSA isolates/refer-
ence strains in forming different levels of biofilm
Bacteria High, N (%) Moderate, N (%) Weak, N (%)
MRSA 4 (44.4) 3 (33.3) 2 (22.2)
MSSA 3 (25) 3 (25) 6 (50)
Fig. 1 Gel electrogram for the PCR-based positive detection of icaA, 
icaD, and FnBPA genes in MRSA and MSSA bacteria
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produced FnBPA type biofilms, so using phage-based 
reduction of biofilms with chemical adjuvant seems 
interesting. Accordingly, the use of anti-MRSA and anti-
MSSA phages in the reduction of MRSA and MSSA bio-
films, respectively, was shown to be successful especially 
when coupled with chemical adjuvant helping denature 
and disintegrate the treated biofilm matrix.
The treated wells in which biofilms were not eliminated 
completely in the first treatment via phage application 
with chemical adjuvant were subjected to a second round 
of treatment. In this instance, the anti-MSSA and anti-
MRSA phages, coupled with chemical adjuvant, were 
applied on the corresponding bacterial biofilms. It was 
found that all the SA biofilms which were remained after 
the first round, 3 weak MSSA PIA and 1 weak MSSA 
FnBPA, were eliminated completely via the second round 
of phages application with chemical adjuvant. Neverthe-
less, for MRSA biofilms which were remained after the 
first round, only 1 weak MRSA PIA and 1 weak MRSA 
FnBPA biofilm were completely eliminated by the second 
round of phages application with chemical adjuvant. This 
indicated the development of resistance by 2/9 (22.2  %) 
of MRSA biofilms and 2/6 (33.3 %) of FnBPA MRSA bio-
films in particular to the attacking phages and this resist-
ance impeded the complete eradication of biofilms in the 
first and second rounds of phages application.
Discussion
Microbial biofilms are considered one of the major health 
problem because they cause chronic infections which 
are difficult to treat, lead to longer hospitalization time, 
and can result in much higher treatment costs [29, 31]. 
Hence, a new approach, rather than the counterproduc-
tive antibiotics, must be used. In the current study, inter-
estingly, all the 9 samples of MRSA and 12 samples of 
MSSA developed biofilms after 24  h. This indicated the 
highly potent ability of both MSSA and MRSA in devel-
oping rapidly biofilms. Moreover, weak production of 
biofilms in MSSA was half of the all biofilms produced 
while in MRSA were only 22.2 %. This provided evidence 
that MRSA production of biofilms is of higher efficacy 
and of faster pace. Ursic et al. stated that MRSA bacteria 
Fig. 2 SEM photos for (left) PIA/PNAG crystalline rough surface cagA-D-positive biofilm of MRSA and (right) smooth proteinacious FnBPA-positive 
biofilm of MRSA
Table 4 The type of  produced biofilms in  MRSA and  MSSA bacteria assessed by  SEM and  PCR along  with their corre-
sponding level of biofilm production
Bacteria PIA‑based biofilm via PCR and rough  
crystalline biofilm via SEM
FnBPA‑based biofilm via PCR  
and smooth proteinacious biofilm via SEM
High, N (%) Moderate, N (%) Weak, N (%) High, N (%) Moderate, N (%) Weak, N (%)
MRSA 1 (11.1) 1 (11.1) 1 (11.1) 3 (33.3) 2 (22.2) 1 (11.1)
MSSA 2 (16.6) 2 (16.6) 4 (33.3) 1 (8.3) 1 (8.3) 2 (16.6)
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have an unrivalled potential of biofilm formation when 
compared with non-MRSA bacteria [30, 32]. Hence, spe-
cial care for treating MRSA biofilms is highly needed.
In the current study, we analyzed the formed biofilms 
of MSSA and MRSA bacteria depending on the nature 
of the biofilm matrix whether it is PIA/PNAG or pro-
teinacious FnBPA type. FnBPA biofilms in MRSA were 
found as double frequency as PIA biofilms while in 
MSSA biofilms the reverse was observed, the frequency 
of PIA biofilms was double that of FnBPA. These findings 
are congruous with findings of several previous studies 
which revealed that protein- mediated biofilm forma-
tion capacity seems to be particularly frequent among the 
highly virulent MRSA isolates, emphasizing the impor-
tance of this type of biofilm structure and its capacity for 
survival and antimicrobial resistance [16, 33]. Therefore, 
FnBPA type biofilm which is found mainly in highly vir-
ulent MRSA can be the key factor for the resilient bio-
films produced by MRSA which lay heavy burden on the 
community medicine, hospital environment, and general 
health issues. From SEM photos, the proteinacious bio-
films were shown with more rigid and compact matrix 
than PIA biofilms. Hence, the proteinacious FnBPA 
biofilms of MRSA appear to be difficult for anti-MRSA 
antibiotic because most of these antibiotics can not get 
through this compact matrix. In a study, it was found 
that even a highly effective drug like Vancomycin failed 
to produce a 2 log reduction in the biofilm embedded 
MRSA bacterial count and most antiseptics were found 
unable to completely eliminate MRSA biofilms on plastic 
or metal surfaces found in hospitals [34].
Accordingly, phage-based approach was taken into 
consideration for the treatment of MSSA and MRSA 
biofilms. A previous study revealed that a staphylococ-
cal phage, GH15, was isolated and the endogenous lytic 
enzyme (LysGH15) was expressed and purified. The lysin 
LysGH15 displayed a broad lytic spectrum; in vitro treat-
ment killed a number of Staphylococcus aureus strains 
rapidly and completely, including the methicillin-resist-
ant Staphylococcus aureus (MRSA) [35]. In addition, 
Table 5 Phage-based reduction of  biofilms, with  or without  using adjuvant chemical, in  PIA and  FnBPA types of  both 
MRSA and SA
Mod represents moderate production of biofilms, Zero describes mean OD values of TCP method less than 0.01
Bacteria Type of biofilm Phage application without chemical adjuvant Phage application with chemical adjuvant
Level of biofilm before: after (score of reduction) Level of biofilm before: after (score of reduction)
SA-1 PIA High: high (0) High: weak (2)
SA-2 PIA Mod: weak (1) Mod: zero (2)
SA-3 PIA weak: zero (1) weak: zero (1)
SA-10 PIA weak: zero (1) weak: zero (1)
SA-5 PIA High: High (0) High: weak (2)
SA-6 PIA weak: zero (1) weak: zero (1)
ATCC 11987 PIA Mod: weak (1) Mod: weak (1)
SA-8 PIA weak: zero (1) weak: zero (1)
Average score of reduction 0.75 1.38
SA-9 FnBPA Mod: Mod (0) Mod: zero (2)
SA-4 FnBPA High: high (0) High: weak (2)
SA-7 FnBPA weak: weak (0) weak: zero (1)
ATCC 27691 FnBPA weak: zero (1) weak: zero (1)
Average score of reduction 0.25 1.5
MR-4 PIA Mod: Mod (0) Mod: zero (2)
MR-5 PIA High: High (0) High: weak (2)
MR-7 PIA weak: zero (1) weak: zero (1)
Average score of reduction 0.33 1.67
MR-1 FnBPA High: high (0) High: zero (3)
MR-2 FnBPA Mod: mod (0) Mod: weak (1)
MR-3 FnBPA High: high (0) High: weak (2)
MR-6 FnBPA weak: zero (1) weak: zero (1)
ATCC 700699 FnBPA Mod: Mod (0) Mod: zero (2)
ATCC 43300 FnBPA High: high (0) High: mod (1)
Average score of reduction 0.17 1.67
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phages can propagate in their bacterial host and phages 
produce depolymerases that hydrolyze biofilm extra-
cellular polymers [36] therefore, phage mixtures or 
engineered phages could provide effective strategies to 
overcome bacterial biofilms. Lytic bacteriophages could 
become a new class of anti-biofilm agents. In the current 
study, when anti-MRSA and anti-MSSA phages with-
out chemical adjuvant were used, findings revealed that 
phage-based reduction was more remarkable in MSSA 
than in MRSA and in PIA than in FnBPA; moreover, 
MRSA FnBPA group was the least responsive to phage-
based reduction of biofilms. This showed the difficulty in 
addressing the problem of MRSA biofilms when phages 
are used alone. This might be attributed to the limited 
capacity of phages’ depolymerases to hydrolyze extracel-
lular matrix of MRSA biofilms especially the proteina-
cious FnBPA type.
As a result of the relatively poor eradication of MRSA 
and MSSA biofilms by applied phages, it was concluded 
that the main obstacle is the extracellular matrix of bio-
films. Hence, a set of chemical reagents were tried to 
disrupt the PIA/PNAG or FnBPA protein matrices in 
parallel with attacking phages to pave the way for phages 
to access the cell wall of bacterial hosts. After a series of 
experiments, 0.08 % Benzenthonium chloride and 0.06 % 
ethanol were used along with applied phages against 
PIA and FnBPA biofilms, respectively. The resultant 
mixture of lytic phages and chemical adjuvant granted 
satisfactory outcomes. After 2 rounds of phages appli-
cation, 100  % of MSSA PIA and MSSA FnBPA biofilms 
were removed completely and for MRSA, only 22.2 % of 
biofilms showed incomplete eradication via resistance 
against attacking phages with chemical adjuvant. The 
current findings gave clue to the best way for enabling 
lytic phages to eradicate efficiently bacterial hosts’ bio-
films. Unfortunately, no previous report was found con-
ducting the same principle of phage-chemical biocontrol 
of MRSA and MSSA. The pioneering findings of the cur-
rent study imply to new, practical, and cheap approaches 
to contain, reduce, or eliminate biofilms which are the 
main refractory source of MRSA and MSSA spread in 
both hospitals and environment. Moreover, the current 
phage: chemical mixture can be used in gel base for the 
prevention of biofilm production on inserted devices into 
human body such as urinary catheters leading to lower-
ing the use of antimicrobial agents.
The successful control and treatment of MRSA and 
MSSA biofilms using phages: chemical mixtures have 
important health advantages. Doolittle et  al. [37] dem-
onstrated that the radial movement of T4 phage particles 
through a biofilm is similar to the process of plaque for-
mation on a lawn of host bacteria, indicating that a sin-
gle dose of phage could treat a biofilm-related infection. 
On the contrary, biofilm organisms are tolerant to anti-
microbial drugs, disinfectants and biocides [38] and high 
concentrations of antimicrobials for prolonged treatment 
durations are normally required to achieve biofilm reduc-
tion or eradication [39]. Another drawback of antimicro-
bial agents is that higher antimicrobial concentrations 
are required to inactivate or eradicate the biofilm cells as 
the biofilm ages [40] while this is not found in the case of 
phages. Moreover, the biofilm extracellular matrix could 
also affect the efficacy of antimicrobial agents because 
of diffusion limitations [38] while phages diffuse more 
easily through alginate gels and extracellular matrix of 
biofilms. Collectively, all the mentioned advantages of 
phage-based control of bacterial biofilms when coupled 
with the currently discovered phage-sparing and biofilm 
matrix- disrupting chemical agent, the resultant weapon 
would be so deadly for biofilms of most notorious bugs 
such as MRSA.
Conclusions
Taken together, it was concluded that the application of 
highly lytic anti-MSSA and anti-MRSA phages along with 
biofilm matrix- disrupting chemicals led to highly suc-
cessful eradication of host biofilms. The used mixtures of 
phages: chemical adjuvants are recommended to be used 
in a large scale evaluation study in order to prepare for 
the introduction of the current approach of MRSA bio-
film control into the routine sanitary procedures done in 
hospitals. Moreover, the current approach can be used 
in the prevention of devices-related infections for the 
in vivo medical instruments, such as urinary catheters.
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